NDC 63323-393
Colistimethate
Colistimethate Sodium
Colistimethate is a Intramuscular; Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Colistimethate Sodium.
| Product ID | 63323-393_40ae8d43-e65a-4533-bb94-babdac91d4b8 |
| NDC | 63323-393 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Colistimethate |
| Generic Name | Colistimethate Sodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2009-12-04 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065364 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | COLISTIMETHATE SODIUM |
| Active Ingredient Strength | 150 mg/2mL |
| Pharm Classes | Polymyxin-class Antibacterial [EPC],Polymyxins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |